Canopy Growth Corp Contractual Obligation, to be Paid, after Year Five
Canopy Growth Corp (CGC) had Contractual Obligation, to be Paid, after Year Five of CAD 57.77 million as of 2022-03-31, per its 10-K filed 2022-05-31.
Discontinued › Notes › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligationDueAfterFifthYear · last filed 2022-05-31
- 2022-03-31: Contractual Obligation, to be Paid, after Year Five 57.77M CAD.
- 2020-03-31: Contractual Obligation, to be Paid, after Year Five 55.55M CAD.
| Period end | Contractual Obligation, to be Paid, after Year Five |
|---|---|
| 2022-03-31 | 57.77M CAD 10-K · filed 2022-05-31 |
| 2020-03-31 | 55.55M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |